Get a Second Opinion Unveils First Pre-Prescription Intelligence System in the U.S.
In a groundbreaking initiative aiming to reshape patient experience, Get a Second Opinion has officially launched the Pre‑Prescription Intelligence platform across the United States. This innovative system introduces a real-time decision-making tool that allows patients to grasp the essential details of their medications before any prescriptions are made. One of its most significant features is the emphasis on patient privacy; the system delivers personalized guidance without requiring any personally identifiable information. This makes it a pioneer in the field of medication intelligence that respects users' anonymity.
The Pre-Prescription Intelligence platform sets a new standard for transparency in medication management. For the first time, patients can review their full medication regimens prior to treatment commencement. Each personalized report generated by the platform ranks available options and simplifies complex FDA Drug Label terminology into layman's terms. It highlights crucial information, including potential risks and contraindications, while offering straightforward guidance specific to each patient's profile. With this revolutionary approach, over 31,000 medical conditions and 14,000 medications are accessible via the site without necessitating account creation.
Users can benefit from a free anonymous profile which allows them to generate personalized 'Second Opinions' with just a click. Initial feedback has been overwhelmingly positive: 97% of users report improved medication plans, and 93% identify lower-cost alternatives during their first experience with the platform. Furthermore, the tool provides essential insights into expected monthly costs and helps patients understand their insurance coverage better, ensuring there are no financial surprises down the line.
CEO Joel Ferman expressed the importance of patient empowerment in this context. He stated, "Patients deserve to be in control before they agree to treatment options—not after problems arise. Pre‑Prescription Intelligence gives the public real‑time visibility into efficacy, safety, interactions, and cost." The platform aims to restore clarity and confidence among patients by translating complex clinical data into easily digestible advice that they can rely on to make well-informed choices.
The underlying technology of Pre-Prescription Intelligence is incredibly robust, employing a comprehensive analysis of FDA data alongside additional clinical parameters, including efficacy indicators, cautions, and boxed warnings. This thorough review culminates in the creation of a high-performance medication intelligence engine capable of delivering actionable insights. Andrew Ossipov, the company’s CTO, remarked on this technical achievement: "By unifying thousands of regulatory records into a single meta-analysis enriched with real-world clinical parameters, we've established a new technical standard for leveraging pharmaceutical information to serve the public effectively."
The infrastructure features a transformation of every medication into a drug data card that synthesizes an average of 60 FDA records. These data cards are packed with clinical parameters, detailing side-effect profiles and interaction indicators—all aimed at giving patients a complete view of their medication landscape before they commence treatment.
Moreover, Get a Second Opinion is expanding its reach through a secure Enterprise API, aimed at hospitals, research institutions, insurers, and health systems that seek scalable, real-time medication intelligence. This API integrates smoothly into existing clinical workflows and enhances decision-making support for care teams within established regulatory frameworks.
Founded on the principle that medication outcomes can be significantly improved through clear, accessible guidance, Get a Second Opinion combines automated literature reviews and extensive pharmaceutical insights to ensure that users have access to fast and effective second opinions regarding their treatments. Sponsored by Google as an Ecosystem Partner and part of the NVIDIA Inception Program, Get a Second Opinion exemplifies innovation at the intersection of technology and healthcare. With the launch of the Pre-Prescription Intelligence platform, the company is poised to redefine how patients interact with their medication regimens, fostering a culture of informed and empowered healthcare decisions.
The Pre-Prescription Intelligence platform sets a new standard for transparency in medication management. For the first time, patients can review their full medication regimens prior to treatment commencement. Each personalized report generated by the platform ranks available options and simplifies complex FDA Drug Label terminology into layman's terms. It highlights crucial information, including potential risks and contraindications, while offering straightforward guidance specific to each patient's profile. With this revolutionary approach, over 31,000 medical conditions and 14,000 medications are accessible via the site without necessitating account creation.
Users can benefit from a free anonymous profile which allows them to generate personalized 'Second Opinions' with just a click. Initial feedback has been overwhelmingly positive: 97% of users report improved medication plans, and 93% identify lower-cost alternatives during their first experience with the platform. Furthermore, the tool provides essential insights into expected monthly costs and helps patients understand their insurance coverage better, ensuring there are no financial surprises down the line.
CEO Joel Ferman expressed the importance of patient empowerment in this context. He stated, "Patients deserve to be in control before they agree to treatment options—not after problems arise. Pre‑Prescription Intelligence gives the public real‑time visibility into efficacy, safety, interactions, and cost." The platform aims to restore clarity and confidence among patients by translating complex clinical data into easily digestible advice that they can rely on to make well-informed choices.
The underlying technology of Pre-Prescription Intelligence is incredibly robust, employing a comprehensive analysis of FDA data alongside additional clinical parameters, including efficacy indicators, cautions, and boxed warnings. This thorough review culminates in the creation of a high-performance medication intelligence engine capable of delivering actionable insights. Andrew Ossipov, the company’s CTO, remarked on this technical achievement: "By unifying thousands of regulatory records into a single meta-analysis enriched with real-world clinical parameters, we've established a new technical standard for leveraging pharmaceutical information to serve the public effectively."
The infrastructure features a transformation of every medication into a drug data card that synthesizes an average of 60 FDA records. These data cards are packed with clinical parameters, detailing side-effect profiles and interaction indicators—all aimed at giving patients a complete view of their medication landscape before they commence treatment.
Moreover, Get a Second Opinion is expanding its reach through a secure Enterprise API, aimed at hospitals, research institutions, insurers, and health systems that seek scalable, real-time medication intelligence. This API integrates smoothly into existing clinical workflows and enhances decision-making support for care teams within established regulatory frameworks.
Founded on the principle that medication outcomes can be significantly improved through clear, accessible guidance, Get a Second Opinion combines automated literature reviews and extensive pharmaceutical insights to ensure that users have access to fast and effective second opinions regarding their treatments. Sponsored by Google as an Ecosystem Partner and part of the NVIDIA Inception Program, Get a Second Opinion exemplifies innovation at the intersection of technology and healthcare. With the launch of the Pre-Prescription Intelligence platform, the company is poised to redefine how patients interact with their medication regimens, fostering a culture of informed and empowered healthcare decisions.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.